Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity.
about
Autophagy and cancerA phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.Peripheral NMDA Receptor/NO System Blockage Inhibits Itch Responses Induced by Chloroquine in Mice.Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugsPrinciples and current strategies for targeting autophagy for cancer treatment.Hendra and nipah infection: pathology, models and potential therapies.Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans.Chloroquine is effective against influenza A virus in vitro but not in vivo.Chloroquine-containing compounds: a patent review (2010 - 2014).Autophagy inhibitors.Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity.Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesAntimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC.Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis.Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.Pathobiology of virus glycosylation: implications to disease and prospects for treatment
P2860
Q26865957-FB3137B0-BDA5-4125-B607-D637904D2D84Q33416266-9EB00000-3F3B-4CE8-A1CA-3799A5F0F135Q33924930-75797448-D0E0-4DB0-9D65-9B30FB826824Q33937865-3DA26DA8-DE25-4464-AADD-ED8DD3EDC867Q34120213-4904BEB8-1EC7-44D7-8491-B78D22AA7654Q34787732-DF8E0FE8-D1CA-4171-81E8-2946168A451AQ35658146-F56CDCA7-F0BD-42BD-B5AE-09576E90E380Q36919663-93E934E2-E3F7-4B5B-81C6-32C51892F4A9Q37087650-E20F6BAC-4F43-48AD-BD2F-B17BC9149D40Q38503439-F814E9F2-9045-4426-AC29-560D597D82F9Q38666985-F8E5B946-D084-4BDE-AB7A-9D6F675E0C89Q38967211-681A7CF7-B9A7-416E-B631-4CC6B119DDDDQ39360987-DCE1F275-B16E-401C-9DBB-FD0EFFDC9BAFQ39420155-B95EB6BC-BD70-4AA3-96ED-246884054724Q39621306-B61D93AA-BFA4-4036-8BE1-789403AAF244Q41943954-34235BF0-E135-4295-9344-25072351E680Q43280688-C1BF4331-36C6-4E15-BE00-F631FA337348Q57202110-7C74258A-21E8-406A-B3B1-38158340B6D6
P2860
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Chloroquine and hydroxychloroq ...... ciency virus (HIV-1) activity.
@ast
Chloroquine and hydroxychloroq ...... ciency virus (HIV-1) activity.
@en
type
label
Chloroquine and hydroxychloroq ...... ciency virus (HIV-1) activity.
@ast
Chloroquine and hydroxychloroq ...... ciency virus (HIV-1) activity.
@en
prefLabel
Chloroquine and hydroxychloroq ...... ciency virus (HIV-1) activity.
@ast
Chloroquine and hydroxychloroq ...... ciency virus (HIV-1) activity.
@en
P2093
P356
P1476
Chloroquine and hydroxychloroq ...... ciency virus (HIV-1) activity.
@en
P2093
Ardis Dee Hoven
Frank Romanelli
Kelly M Smith
P304
P356
10.2174/1381612043383791
P577
2004-01-01T00:00:00Z